AZABICYCLO [3.2.1]OCTYL DERIVATIVES AS 11 BETA-HSD1 MODULATORS
申请人:Exelixis, Inc.
公开号:EP2280966A1
公开(公告)日:2011-02-09
NOVEL BICYCLIC PYRIDINONES
申请人:Pfizer Inc.
公开号:EP2691393A1
公开(公告)日:2014-02-05
US8697673B2
申请人:——
公开号:US8697673B2
公开(公告)日:2014-04-15
US9067934B2
申请人:——
公开号:US9067934B2
公开(公告)日:2015-06-30
[EN] AZABICYCLO [3. 2. I] OCTYL DERIVATIVES AS 11 BETA-HSDL MODULATORS<br/>[FR] DÉRIVÉS AZABICYCLO[3.2.1]OCTYLES EN TANT QUE MODULATEURS DE 11-BÊTA-HSDL
申请人:EXELIXIS INC
公开号:WO2009114173A1
公开(公告)日:2009-09-17
A compound according to Formula: (A) or a pharmaceutically acceptable salt thereof, wherein R11, G1 and G2 are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.